Nath Bio-Genes (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Nath Bio-Genes (India) Ltd. on BSE

Search Inside the pdf :

Nath Bio-Genes (India) Ltd.

11 Jun 2025

210.79

3.51%

SAST

Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) …

BSE India

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 11, 2025 for Ferry Fax Farms Pvt Ltd

pdf

Nath Bio-Genes (India) Ltd.

03 Jun 2025

210.79

3.51%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Issue of Duplicate Share Certificate

pdf

Nath Bio-Genes (India) Ltd.

30 May 2025

210.79

3.51%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report

pdf

Nath Bio-Genes (India) Ltd.

21 May 2025

210.79

3.51%

Corp. Note

Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Intimation for issue of Duplicate Share Certificate

pdf

Nath Bio-Genes (India) Ltd.

15 May 2025

210.79

3.51%

SAST

Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual Fund

pdf

Nath Bio-Genes (India) Ltd.

02 May 2025

210.79

3.51%

Earnings Call

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earning call held on 30th April 2025

pdf

Nath Bio-Genes (India) Ltd.

02 May 2025

210.79

3.51%

Company Update

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Revised Disclosure for Resignation of Ms. Ashu Jain from the post of Independent Director of the Company.

pdf

Nath Bio-Genes (India) Ltd.

29 Apr 2025

210.79

3.51%

Investor Presentation

Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation on Audited Financial Results as on 31st March 2025

pdf

Nath Bio-Genes (India) Ltd.

29 Apr 2025

210.79

3.51%

Result

Nath Bio-Genes (India) Ltd - 537291 - Financial Results As On 31St March 2025

BSE India

The Board in the meeting held today on 29th April 2025 has approved the Standalone and Consolidated Financial Results as on 31st Match 2025.

pdf

	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	55.83	37.35	43.45	49.5%	28.5%
Operating Profit Qtr	0.41	8.04	3.93	-94.9%	-89.6%
Net Profit Qtr	1.48	2.65	2.62	-44.2%	-43.5%
Earning Per Share Adjusted latest Qtr	0.78	1.39	1.38	-43.9%	-43.5%

* Consolidated data

Detailed Results

Nath Bio-Genes (India) Ltd.

29 Apr 2025

210.79

3.51%

Board Meeting

Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Outcome Of Board Meeting

BSE India

The Board on meeting held today on 29th April 2025 has approved the following. 1. Standalone Audited Financial Results as on 31st March 2025 along with Auditors Report 2. Consolidated Audited Financial Results as on 31st March 2025 along with Auditors Report 3. Other Disclosure/ Announcements.

pdf

Is Nath Bio-Genes (India) Ltd. worth buying?

125 Votes:

Buy 84.0%

Sell 11.2%

Hold 4.8%